Business Wire

Diligent Announces Shiza Shahid, Moisés Naím, Michael Montelongo, Veena Ramani and More to Deliver Impactful Sessions at the Fourth Annual Modern Governance Summit

14.9.2022 21:37:00 EEST | Business Wire | Press release

Share

Diligent, the global leader in modern governance providing SaaS solutions across governance, risk, compliance, audit and ESG, today announced keynote speakers and agenda highlights for its annual Modern Governance Summit (MGS), taking place in Austin, Texas and online between September 12-14, 2022.

World-renowned leaders will take the stage to explore key issues like risk and strategy; ethics and compliance; environmental, social and corporate governance (ESG); digital transformation and more. Attendees will have the opportunity to network with peers and hear from industry experts in impactful sessions like “The World Hangs in the Balance: Getting ESG Right”; “Living Your Purpose: Putting Your Values and Ethics First in Business”; “The Evolving Risk Landscape – Implications of Geopolitical and Financial Risk”; “What Has Changed (and what hasn't) Since SOX”; and “The Courage to Lead: What it Takes to Build a Purpose-Driven Enterprise.” A full agenda can be found here.

Just a few of the inspirational speakers at this year’s MGS include:

  • Shiza Shahid, an entrepreneur, investor, technologist, and impact leader, co-founded the Malala Fund with Nobel Prize winner Malala Yousafzai and led the organization as founding CEO. She is now the co-founder of Our Place, a mission-driven e-commerce startup that is creating products and telling stories that celebrate cultural traditions and reinvest in communities, through the lens of food and home-cooking. Shiza will deliver a session on putting values and ethics first in business.
  • Moisés Naím, internationally syndicated columnist and best-selling author. In the early 1990s, Dr. Naím served as Venezuela’s Minister of Trade and Industry, as director of Venezuela’s Central Bank, and as executive director of the World Bank. Dr. Naím will be a keynote speaker discussing geopolitical risk and strategy.
  • Sherron Watkins, former Vice President of Corporate Development at the Enron Corporation, whose exposure of corporate misconduct paved the way for the enactment of SOX corporate reform law. Sherron will be part of a panel discussion on what has changed – and what hasn’t – since Sarbanes-Oxley Act was enacted 20 years ago.
  • Cynthia Cooper, accountant who formerly served as the Vice President of Internal Audit at WorldCom where her team exposed the largest accounting fraud in U.S. history. Cynthia will also be part of the panel on what has changed since SOX.
  • The Honorable Michael Montelongo, President and CEO of GRC Advisory Services, LLC, and former Bush White House appointee who served as the 19th assistant secretary for financial management and CFO of the US Air Force and the first Latino in that role. Michael will join Cynthia Cooper and Sherron Watkins in the SOX panel discussion.
  • Veena Ramani, Research Director at FCLTGlobal and expert in corporate governance, climate change and ESG issues. Veena will be part of panel discussions on preparing for shareholder and stakeholder ESG activism and getting ESG right.
  • Enrique Acevedo, CBS Correspondent who has interviewed some of the world’s biggest leaders, including President Barack Obama, Melinda Gates, Kofi Annan and more. Enrique will moderate “The World Hangs in the Balance: Getting ESG Right.”

“Organizations today are navigating complex and ever-evolving business landscapes, where uncertainty is omnipresent,” said Brian Stafford, CEO of Diligent. “In this era, the role of governance, risk, compliance, audit and ESG professionals has become even more critical. We’re honored to be engaging with this community of leaders in person once again as we explore the intersection of performance, risk and purpose, and to welcome this year’s roster of world-renowned speakers.”

Now in its fourth year, the Modern Governance Summit is the largest governance, risk and compliance (GRC) event of the year bringing together thousands of leaders from board members to corporate secretaries, general counsels, chief compliance officers and other governance professionals. Designed to elevate GRC practices and explore key issues facing organizations today, attendees benefit from 2.5 days of thought leadership, networking and product training opportunities.

The event is open to the press and most sessions will be on the record. For more information and to register contact: press@diligent.com

About Diligent

Diligent is the global leader in modern governance, providing SaaS solutions across governance, risk, compliance, audit and ESG. Serving more than 1 million users from over 25,000 customers around the world, we empower transformational leaders with software, insights and confidence to drive greater impact and lead with purpose. Learn more at diligent.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contact
Julia Hanbury
Senior Communications Manager, Diligent
+1-604-669-4225
Jhanbury@diligent.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufacturing site. All other aspects of the BLA, including safety- and efficacy-related parts, did not solicit deficiencies to be addressed. The FDA made observations during the PLI for which Galderma is putting in place corrective and preventive actions. Galderma will also be seeking further guidance through continued open dialogue with the FDA toward resolution of the relevant observations. Galderma plans to rapidly respond to the CRL and advancing RelabotulinumtoxinA in the U.S. remains a top priority. The ob

EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 04:45:00 EEST | Press release

EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia

Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 02:56:00 EEST | Press release

Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting

FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 19:19:00 EEST | Press release

Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease and lung cancer,” she added. “More broadly, it reinforces the agency’s science-based approach to evaluating products across the co

Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 18:00:00 EEST | Press release

Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye